glycine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“There were no differences in mortality (glycine group, 63.6% vs control group, 52.2%, p = 0.60) nor in any other major outcome.”
Quoted verbatim from Glycine by enteral route does not improve major clinical outcomes in severe COVID-19: a randomized clinical pilot trial.. - Study
- RCT
- Dose
- 0.5 g/kg/day glycine by the enteral route
- Population
- Inpatients with severe COVID-19 requiring mechanical ventilation; usual care in both arms, glycine added in the experimental arm; open label
Glycine by enteral route does not improve major clinical outcomes in severe COVID-19: a randomized clinical pilot trial.2024PMID:38773199Permalink
Keep reading
- Everything the graph holds on glycine
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4QE3V77K4VBWS8Z2XVK2HPE